Meet our 2022 speakers


Innovation and investment across biotech, medtech and healthtech

Simon Amies, Partner, Covington & Burling

Simon Amies

Partner
Covington & Burling
Madeleine Armstrong, News Editor, Vantage

Madeleine Armstrong

News Editor
Evaluate
Gil Bar-Nahum, MD, Global Healthcare Investment Banking, Jefferies

Gil Bar-Nahum

MD, Global Healthcare Investment Banking
Jefferies
Vijay Barathan, Senior Principal, Optum Ventures 300x

Vijay Barathan

Partner
Optum Ventures
Jenny Barnett, CEO, Monument Tx

Jenny Barnett

CEO
Monument Tx
Catherine Boule, Managing Partner, Karista

Catherine Boule

Managing Partner
Karista
Dominique Bridon, CEO, Diaccurate SA

Dominique Bridon

CEO
Diaccurate SA
Philip Broke, Partner, White & Case

Philip Broke

Partner
White & Case
Carlos Buesa, CEO, ORYZON

Carlos Buesa

CEO
ORYZON
Tom Burt, Partner, Sofinnova

Tom Burt

Partner
Sofinnova
Olivia Cavlan, Chief Corporate Development & Strategy Officer, Alchemab

Olivia Cavlan

Chief Corporate Development & Strategy Officer
Alchemab
Vivien de Tusch-Lec, General Partner, RYSE Asset Management

Vivien de Tusch-Lec

General Partner
RYSE Asset Management
Martin Forbes, Partner, White & Case

Martin Forbes

Partner
White & Case
Hans Gangeskar, Co-Founder and Board Member, Nurx

Hans Gangeskar

CEO
Overture Life
Matthew Gehl, Partner, Covington & Burling

Matthew Gehl

Partner
Covington & Burling
Tim Haines, Managing Partner, Abingworth Life Science

Tim Haines

Managing Partner
Abingworth Life Science
Yahel Halamish, Principal, Nina Capital

Yahel Halamish

Principal
Nina Capital
Giles Hamilton, CEO, ODx Innovations

Giles Hamilton

CEO
ODx Innovations
William Hicks, Co-Chair, Securities & Capital Markets Practice, Mintz

William Hicks

Co-chair Securities, Capital Markets Group
Mintz
Anne Horgan, Partner, Cambridge Innovation Capital

Anne Horgan

Partner
CIC
Casper Johansen, Head of Scouting and Innovation Sourcing - Global Business Development, Ferring Pharmaceuticals

Casper Johansen

Head of Scouting and Innovation Sourcing - Global Business Development
Ferring Pharmaceuticals
Emmie Jones, Partner, White & Case

Emmie Jones

Partner
White & Case
Wouter Joustra, General Partner, Forbion 300x

Wouter Joustra

General Partner
Forbion
Sahil Kirpekar, Head of Business Development, Otsuka

Sahil Kirpekar

Head of Business Development
Otsuka
Olga Krylova, Director, Global Business Development, Otsuka

Olga Krylova

Director, Global Business Development
Otsuka
Dima Kuzmin, Managing Director, 4BIO Capital

Dima Kuzmin

Managing Partner
4BIO Capital
Jenny Laird, VP Search & Evaluation, Lilly

Jenny Laird

VP Search & Evaluation
Lilly
Laura Lane, VP Venture Sciences - Europe, Lilly

Laura Lane

VP Venture Sciences - Europe
Lilly
Andrew Levin, Managing Partner, RA Capital Management

Andrew Levin

Managing Partner
RA Capital Management
Oren Livne, Partner, Baker McKenzie

Oren Livne

Partner, Global Life Sciences Transactions
Baker McKenzie
Joseph Lydon, Associate Partner, McKinsey & Company

Joseph Lydon

Associate Partner
McKinsey
Guillem Masferrer, Investment Director, Asabys

Guillem Masferrer

Investment Director
Asabys
Jessica McCreadie, Principal, Octopus Ventures

Jess McCreadie

Principal
Octopus Ventures
Robbie McLaren, Partner, Latham & Watkins

Robbie McLaren

Partner
Latham & Watkins
Matthias Müllenbeck, SVP, Head Global BD & Alliance Management, Merck KGaA

Matthias Müllenbeck

SVP, Head Global BD & Alliance Management
Merck KGaA
Hugh Nuthall, Senior Director, Search & Evaluation Neuroscience, Eli Lilly and Company

Hugh Nuthall

Senior Director, Search & Evaluation Neuroscience
Eli Lilly and Company
Geraldine O’Keeffe, Partner, LSP

Geraldine O'Keeffe

Partner
EQT Life Sciences
Samantha Peacock, Associate, Latham & Watkins

Samantha Peacock

Associate
Latham & Watkins
Jan Peutzfeldt, SVP Global Marketing and Global BD, Ferring Pharmaceuticals

Jan Peutzfeldt

SVP Global Marketing and Global BD
Ferring Pharmaceuticals
Catherine Pickering, CEO, iOnctura 300x

Catherine Pickering

CEO
iOnctura
Joachim Rautter, Managing Partner, Peppermint Venture Partners GmbH 300x

Joachim Rautter

Managing Partner
Peppermint Venture Partners
David Reynolds, CEO, LoQus 23

David Reynolds

CEO
LoQus 23
Michael Rice, Founding Partner, LifeSci Partners

Michael Rice

Founding Partner
LifeSci Partners
Armin Rump, Associate Director, Global Business Development, Otsuka

Armin Rump

Associate Director, Global Business Development
Otsuka
Jorge Santos da Silva, CEO, Moonlake Therapeutics

Jorge Santos da Silva

CEO
Moonlake Therapeutics
Julie Schieber, Associate, Baker McKenzie

Julie Schieber

Partner
Baker McKenzie
Hiroshi Sheraton, Partner, Baker McKenzie

Hiroshi Sheraton

Partner
Baker McKenzie
Owen Smith, Partner, 4BIO Capital

Owen Smith

Partner
4BIO Capital
Alexandra Taracanova, Director, Strategic Partnerships, RTW Investments

Alexandra Taracanova

Director, Strategic Partnerships
RTW Investments
Tina Tan, Executive Editor, FirstWord HealthTech

Tina Tan

Executive Editor
FirstWord HealthTech
Brandon Thompson, Special Counsel, Covington

Brandon Thompson

Partner
Covington & Burling
Rebecca Todd, Investment Director, Longwall Venture Partners

Rebecca Todd

Investment Director
Longwall Venture Partners
Daniel Turgel, Partner, White & Case

Daniel Turgel

Partner
White & Case
Karina Vazirova, Co-Founder, Femtech Lab

Karina Vazirova

Co-Founder & CEO
FemTech Lab
Felice Verduyn-Van-Weegen, Partner, EQT Group

Felice Verduyn-Van-Weegen

Partner
EQT Group
Charles Waddell, Partner, Pinsent Masons

Charles Waddell

Partner
Pinsent Masons
Julie Yeni, Partner, Life Sciences, Baker McKenzie

Julie Yeni

Partner, Life Sciences
Baker McKenzie
Alexandra Zemp, Partner, McKinsey

Alexandra Zemp

Partner
McKinsey
Emily Cridland, Partner, Latham & Watkins

Emily Cridland

Partner
Latham & Watkins

DOWNLOAD BROCHURE